Brizio Moreno‐Jaime

441 total citations
6 papers, 105 citations indexed

About

Brizio Moreno‐Jaime is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Brizio Moreno‐Jaime has authored 6 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Surgery. Recurrent topics in Brizio Moreno‐Jaime's work include Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Brizio Moreno‐Jaime is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Brizio Moreno‐Jaime collaborates with scholars based in Mexico, Poland and Russia. Brizio Moreno‐Jaime's co-authors include Rocío Bautista‐Pérez, Juan Ramón Zapata‐Morales, Flavio Martínez-Morales, Guillermo J. Ruiz‐Delgado, Luz Tarín‐Arzaga, Olga Graciela Cantú‐Rodríguez, Guillermo J. Ruíz‐Argüelles, José Carlos Jaime‐Pérez, Cesar Homero Gutiérrez‐Aguirre and David Gómez‐Almaguer and has published in prestigious journals such as Cancer, Annals of Oncology and Supportive Care in Cancer.

In The Last Decade

Brizio Moreno‐Jaime

6 papers receiving 104 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brizio Moreno‐Jaime Mexico 4 35 29 25 24 24 6 105
S Nowak Poland 7 20 0.6× 12 0.4× 6 0.2× 11 0.5× 10 0.4× 22 145
Jesse M. Tettero Netherlands 6 30 0.9× 15 0.5× 3 0.1× 7 0.3× 16 0.7× 11 105
Marek Bronisz Poland 5 135 3.9× 22 0.8× 18 0.7× 15 0.6× 4 0.2× 7 212
Anna Ludovica Fracanzani Italy 6 37 1.1× 6 0.2× 50 2.0× 35 1.5× 8 0.3× 9 237
Francesca Guidetti Switzerland 6 8 0.2× 20 0.7× 8 0.3× 5 0.2× 11 0.5× 12 64
Floor CJI Moenen Netherlands 4 83 2.4× 17 0.6× 7 0.3× 16 0.7× 10 0.4× 11 120
Ainoon Othman Malaysia 9 51 1.5× 69 2.4× 7 0.3× 14 0.6× 8 0.3× 22 287
Eugenio Piro Italy 7 76 2.2× 13 0.4× 5 0.2× 4 0.2× 51 2.1× 15 115
Annick Vanclooster Belgium 6 80 2.3× 13 0.4× 27 1.1× 11 0.5× 9 0.4× 8 176
Moataz Ellithi United States 7 15 0.4× 14 0.5× 10 0.4× 14 0.6× 69 2.9× 25 153

Countries citing papers authored by Brizio Moreno‐Jaime

Since Specialization
Citations

This map shows the geographic impact of Brizio Moreno‐Jaime's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brizio Moreno‐Jaime with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brizio Moreno‐Jaime more than expected).

Fields of papers citing papers by Brizio Moreno‐Jaime

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brizio Moreno‐Jaime. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brizio Moreno‐Jaime. The network helps show where Brizio Moreno‐Jaime may publish in the future.

Co-authorship network of co-authors of Brizio Moreno‐Jaime

This figure shows the co-authorship network connecting the top 25 collaborators of Brizio Moreno‐Jaime. A scholar is included among the top collaborators of Brizio Moreno‐Jaime based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brizio Moreno‐Jaime. Brizio Moreno‐Jaime is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Makharadze, Tamta, Ruben G.W. Quek, Tamar Melkadze, et al.. (2023). Quality of life with cemiplimab plus chemotherapy for first‐line treatment of advanced non–small cell lung cancer: Patient‐reported outcomes from phase 3 EMPOWER‐Lung 3. Cancer. 129(14). 2256–2265. 8 indexed citations
3.
Gogishvili, Miranda, Tamar Melkadze, Tamta Makharadze, et al.. (2021). LBA51 EMPOWER-Lung 3: Cemiplimab in combination with platinum doublet chemotherapy for first-line (1L) treatment of advanced non-small cell lung cancer (NSCLC). Annals of Oncology. 32. S1328–S1328. 11 indexed citations
4.
Ferrigno, Ana S., David E. Hinojosa-González, Carlos Cruz, et al.. (2020). Factors associated with the desire to undergo post-mastectomy breast reconstruction in a Mexican breast cancer center. Supportive Care in Cancer. 29(5). 2679–2688. 2 indexed citations
5.
Gómez‐Almaguer, David, Luz Tarín‐Arzaga, Brizio Moreno‐Jaime, et al.. (2013). High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia. European Journal Of Haematology. 90(6). 494–500. 42 indexed citations
6.
Moreno‐Jaime, Brizio, et al.. (2012). Autocrine modulation of glucose transporter SGLT2 by IL-6 and TNF-α in LLC-PK1 cells. Journal of Physiology and Biochemistry. 68(3). 411–420. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026